Heterosis Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.80 Cr
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.50 Cr
- Revenue Growth -0.95%
- Profit Growth -144970.56%
- Ebitda -164898.50%
- Net Worth -9927.01%
- Total Assets -0.70%
About Heterosis Biotech
Heterosis Biotech Private Limited (HBPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 October 2007 and has a history of 17 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Hi-Gene Seeds (India) Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.80 Cr.
The company has closed loans amounting to ₹4.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Narayan Patankar and Ashish Khatarkar serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01119TG2007PTC056033
- Company No.
056033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Oct 2007
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Heterosis Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayan Patankar  | Director | 22-Apr-2022 | Current |
| Ashish Khatarkar | Director | 22-Apr-2022 | Current |
Financial Performance of Heterosis Biotech.
Heterosis Biotech Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 0.95% decrease. The company also saw a substantial fall in profitability, with a 144970.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 9927.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heterosis Biotech?
In 2017, Heterosis Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Honey Bee Crop Care Private LimitedNarayan Patankar and Ashish Khatarkar are mutual person
- Dinero Wealth Private Limited
Narayan Patankar and Ashish Khatarkar are mutual person
- Betul Oils And Feeds Private Limited
Narayan Patankar and Ashish Khatarkar are mutual person
- Navinya Multitrade Private Limited
Narayan Patankar and Ashish Khatarkar are mutual person
- Green Holdings Private Limited
Narayan Patankar and Ashish Khatarkar are mutual person
- Shreyans Credit And Capital Pvt Ltd
Narayan Patankar and Ashish Khatarkar are mutual person
Charges (Loans)
₹0
₹4.50 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 4.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Apr 2008 | Bank Of India | ₹4.50 Cr | Satisfied |
How Many Employees Work at Heterosis Biotech?
Unlock and access historical data on people associated with Heterosis Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heterosis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heterosis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
